EVALUATION OF THE SAFETY AND EFFICACY OF TRIPLE DRUG COMBINATION OF VOGLIBOSE 0.2 MG, GLIMEPIRIDE 1MG/ 2MG AND METFORMIN 500 MG IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH DUAL THERAPY

Balamurugan R,Ved Prakash,Sreenivasa Murthy L,Vijay Kumar,Dilip Shah,Manjula S,Krishna Kumar M
DOI: https://doi.org/10.36106/ijsr/9409752
2024-01-01
International Journal of Scientific Research
Abstract:Background: Combining oral anti-hyperglycaemic agents with different mechanism of action produces additive effects, allowing the use of submaximal doses of the agents, thereby reducing the side effects and increasing the complementary benets on cardiovascular risk factors. Objectives: To compare the efcacy and safety of triple drug combination of Voglibose 0.2 mg, Glimepiride 1mg/2mg and Metformin SR 500 mg in type 2 diabetes mellitus (T2DM) patients, inadequately controlled with dual therapy. Methodology: This was an open labelled, nonrandomized, multi-centric, phase IV clinical study where the subjects were divided into two groups: GM V Arm, subjects were given xed dose 1 combination of Voglibose (0.2 mg) + Glimepiride (1 mg) + Metformin SR (500 mg) and GM VArm,subjects were given xed dose combination of 2 Voglibose (0.2 mg) + Glimepiride (2 mg) + Metformin SR (500 mg) twice daily. The primary efcacy endpoint was the change in HbA1c (%) from baseline to end of the study. At 12 weeks, voglibose reduced HbA1c to 6.88 ± 0.85 in GM VArm and to 7.40 ± 1.24 in GM VArm, which Results: 1 2 was statistically signicant (P<0.001). The PPG reductions in both the Arms were signicant compared to baseline, but no statistically signicant changes in body weight, TC, HDL, LDL, VLDL, TG was observed. The reduction in the FPG at week 12 was signicant (P<0.001) in both GM1V Arm and GM VArm. The most common adverse event was fever in 2 subjects (1.98%) and headache, dryness of palms and vomiting in one subject 2 (0.99%). Conclusion: The combination of Voglibose (0.2 mg) + Glimepiride (1/2 mg) +Metformin SR (500 mg) is effective, safe and well tolerated, thus this is an important armamentarium in the management of patients with uncontrolled T2DM.
What problem does this paper attempt to address?